{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:14:17Z","timestamp":1762521257887},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2008,11,4]],"date-time":"2008-11-04T00:00:00Z","timestamp":1225756800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1007\/s00417-008-0983-4","type":"journal-article","created":{"date-parts":[[2008,11,3]],"date-time":"2008-11-03T09:56:49Z","timestamp":1225706209000},"page":"661-666","source":"Crossref","is-referenced-by-count":16,"title":["Ocular involvement in Adamantiades-Beh\u00e7et\u2019s disease in Berlin, Germany"],"prefix":"10.1007","volume":"247","author":[{"given":"Lothar","family":"Krause","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Katrin","family":"K\u00f6hler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Altenburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nestor","family":"Papoutsis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christos C.","family":"Zouboulis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uwe","family":"Pleyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Stroux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael H.","family":"Foerster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,11,4]]},"reference":[{"key":"983_CR1","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00430-002-0167-5","volume":"192","author":"CC Zouboulis","year":"2003","unstructured":"Zouboulis CC, May T (2003) Pathogenesis of Adamantiades-Behcet\u2019s disease. Med Microbiol Immunol 192:149\u2013155 doi: 10.1007\/s00430-002-0167-5","journal-title":"Med Microbiol Immunol"},{"key":"983_CR2","first-page":"133","volume":"31","author":"I Kotter","year":"2004","unstructured":"Kotter I, Vonthein R, Muller CA, Gunaydin I, Zierhut M, Stubiger N (2004) Behcet\u2019s disease in patients of German and Turkish origin living in Germany: a comparative analysis. J Rheumatol 31:133\u2013139","journal-title":"J Rheumatol"},{"key":"983_CR3","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00347-004-1166-2","volume":"102","author":"L Krause","year":"2005","unstructured":"Krause L (2005) Adamantiades-Behcet\u2019s disease. Ophthalmologe 102:329\u2013334 doi: 10.1007\/s00347-004-1166-2","journal-title":"Ophthalmologe"},{"key":"983_CR4","first-page":"488","volume":"150","author":"CC Zouboulis","year":"1999","unstructured":"Zouboulis CC (1999) Epidemiology of Adamantiades-Behcet\u2019s disease. Ann Med Interne (Paris) 150:488\u2013498","journal-title":"Ann Med Interne (Paris)"},{"issue":"suppl 42","key":"983_CR5","first-page":"S125","volume":"24","author":"NG Papoutsis","year":"2006","unstructured":"Papoutsis NG, Abdel-Naser MB, Altenburg A et al (2006) Prevalence of Adamantiades-Beh\u00e7et\u2019s disease in Germany and the municipality of Berlin: Results of a nationwide survey. Clin Exp Rheumatol 24(suppl 42):S125, Erratum in Clin Exp Rheumatol (2007) 25:507\u2013508","journal-title":"Clin Exp Rheumatol"},{"issue":"suppl 42","key":"983_CR6","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1610-0387.2006.05841.x","volume":"4","author":"A Altenburg","year":"2006","unstructured":"Altenburg A, Papoutsis N, Orawa H, Martus P, Krause L, Zouboulis CC (2006) Epidemiology and clinical manifestations of Adamantiades-Behcet disease in Germany - current pathogenetic concepts and therapeutic possibilities. J Dtsch Dermatol Ges 4:49\u201364, quiz 65\u201366 doi: 10.1111\/j.1610-0387.2006.05841.x","journal-title":"J Dtsch Dermatol Ges"},{"key":"983_CR7","first-page":"1078","volume":"335","author":"International Study Group for Behcet\u2019s Disease","year":"1990","unstructured":"International Study Group for Behcet\u2019s Disease (1990) Criteria for diagnosis of Behcet\u2019s disease. Lancet 335:1078\u20131080","journal-title":"Lancet"},{"key":"983_CR8","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1046\/j.1365-4362.2003.01893.x","volume":"42","author":"G Azizlerli","year":"2003","unstructured":"Azizlerli G, Kose AA, Sarica R et al (2003) Prevalence of Behcet\u2019s disease in Istanbul, Turkey. Int J Dermatol 42:803\u2013806 doi: 10.1046\/j.1365-4362.2003.01893.x","journal-title":"Int J Dermatol"},{"key":"983_CR9","first-page":"225","volume":"77","author":"S Mishima","year":"1979","unstructured":"Mishima S, Masuda K, Izawa Y, Mochizuki M, Namba K (1979) The eighth Frederick H. Verhoeff Lecture. presented by Saiichi Mishima, MD Behcet\u2019s disease in Japan: ophthalmologic aspects. Trans Am Ophthalmol Soc 77:225\u2013279","journal-title":"Trans Am Ophthalmol Soc"},{"key":"983_CR10","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S0021-5155(99)00029-5","volume":"43","author":"K Ando","year":"1999","unstructured":"Ando K, Fujino Y, Hijikata K, Izawa Y, Masuda K (1999) Epidemiological features and visual prognosis of Behcet\u2019s disease. Jpn J Ophthalmol 43:312\u2013317 doi: 10.1016\/S0021-5155(99)00029-5","journal-title":"Jpn J Ophthalmol"},{"key":"983_CR11","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s10067-005-0058-4","volume":"25","author":"A Hamdan","year":"2006","unstructured":"Hamdan A, Mansour W, Uthman I, Masri AF, Nasr F, Arayssi T (2006) Behcet\u2019s disease in Lebanon: clinical profile, severity and two-decade comparison. Clin Rheumatol 25:364\u2013367 doi: 10.1007\/s10067-005-0058-4","journal-title":"Clin Rheumatol"},{"key":"983_CR12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/0-306-48382-3_5","volume":"528","author":"F Shahram","year":"2003","unstructured":"Shahram F, Davatchi F, Nadji A et al (2003) Recent epidemiological data on Behcet\u2019s disease in Iran. The 2001 survey. Adv Exp Med Biol 528:31\u201336 doi: 10.1007\/0-306-48382-3_5","journal-title":"Adv Exp Med Biol"},{"key":"983_CR13","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.ophtha.2003.07.018","volume":"111","author":"A Yoshida","year":"2004","unstructured":"Yoshida A, Kawashima H, Motoyama Y et al (2004) Comparison of patients with Behcet\u2019s disease in the 1980s and 1990s. Ophthalmology 111:810\u2013815 doi: 10.1016\/j.ophtha.2003.07.018","journal-title":"Ophthalmology"},{"key":"983_CR14","first-page":"246","volume":"4","author":"M Zierhut","year":"1995","unstructured":"Zierhut M, Saal J, Pleyer U, Kotter I, Durk H, Fierlbeck G (1995) Behcet\u2019s disease: epidemiology and eye manifestations in German and Mediterranean patients. Ger J Ophthalmol 4:246\u2013251","journal-title":"Ger J Ophthalmol"},{"key":"983_CR15","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/00061198-200412000-00002","volume":"13","author":"U Elgin","year":"2004","unstructured":"Elgin U, Berker N, Batman A (2004) Incidence of secondary glaucoma in behcet disease. J Glaucoma 13:441\u2013444 doi: 10.1097\/00061198-200412000-00002","journal-title":"J Glaucoma"},{"key":"983_CR16","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ajo.2004.03.022","volume":"138","author":"I Tugal-Tutkun","year":"2004","unstructured":"Tugal-Tutkun I, Onal S, Altan-Yaycioglu R, Huseyin Altunbas H, Urgancioglu M (2004) Uveitis in Behcet disease: an analysis of 880 patients. Am J Ophthalmol 138:373\u2013380 doi: 10.1016\/j.ajo.2004.03.022","journal-title":"Am J Ophthalmol"},{"key":"983_CR17","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1177\/112067210201200514","volume":"12","author":"PC Ozdal","year":"2002","unstructured":"Ozdal PC, Ortac S, Taskintuna I, Firat E (2002) Posterior segment involvement in ocular Behcet\u2019s disease. Eur J Ophthalmol 12:424\u2013431","journal-title":"Eur J Ophthalmol"},{"key":"983_CR18","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1055\/s-2000-10515","volume":"216","author":"D Krist","year":"2000","unstructured":"Krist D, Sch\u00f6nherr U, Wenkel H (2000) Adamantiadis-Behcet syndrome: fluorescein angiography and choroid ischemia. Klin Monatsbl Augenheilkd 216:45\u201350 doi: 10.1055\/s-2000-10515","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"983_CR19","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1136\/bjo.70.8.589","volume":"70","author":"D Benezra","year":"1986","unstructured":"Benezra D, Cohen E (1986) Treatment and visual prognosis in Behcet\u2019s disease. Br J Ophthalmol 70:589\u2013592 doi: 10.1136\/bjo.70.8.589","journal-title":"Br J Ophthalmol"},{"key":"983_CR20","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3349\/ymj.1997.38.6.423","volume":"38","author":"A Gurler","year":"1997","unstructured":"Gurler A, Boyvat A, Tursen U (1997) Clinical manifestations of Behcet\u2019s disease: an analysis of 2147 patients. Yonsei Med J 38:423\u2013427","journal-title":"Yonsei Med J"},{"key":"983_CR21","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1076\/ocii.10.1.53.10326","volume":"10","author":"A Ambresin","year":"2002","unstructured":"Ambresin A, Tran T, Spertini F, Herbort C (2002) Behcet\u2019s disease in Western Switzerland: epidemiology and analysis of ocular involvement. Ocul Immunol Inflamm 10:53\u201363 doi: 10.1076\/ocii.10.1.53.10326","journal-title":"Ocul Immunol Inflamm"},{"key":"983_CR22","first-page":"599","volume":"79","author":"RM Torres","year":"2004","unstructured":"Torres RM, Yanez B, Herreras JM, Calonge M (2004) Ocular Behcet disease. Retrospective study. Arch Soc Esp Oftalmol 79:599\u2013603","journal-title":"Arch Soc Esp Oftalmol"},{"key":"983_CR23","first-page":"413","volume":"89","author":"YM Chung","year":"1990","unstructured":"Chung YM, Yeh TS, Sheu MM et al (1990) Behcet\u2019s disease with ocular involvement in Taiwan: a joint survey of six major ophthalmological departments. J Formos Med Assoc 89:413\u2013417","journal-title":"J Formos Med Assoc"},{"key":"983_CR24","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1076\/0927-3948(200009)831-KFT141","volume":"8","author":"M Muhaya","year":"2000","unstructured":"Muhaya M, Lightman S, Ikeda E et al (2000) Behcet\u2019s disease in Japan and in Great Britain: a comparative study. Ocul Immunol Inflamm 8:141\u2013148 doi: 10.1076\/0927-3948(200009)8:3;1-K;FT141","journal-title":"Ocul Immunol Inflamm"},{"key":"983_CR25","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1601-0825.2005.01144.x","volume":"12","author":"M Escudier","year":"2006","unstructured":"Escudier M, Bagan J, Scully C (2006) Number VII Behcet\u2019s disease (Adamantiades syndrome). Oral Dis 12:78\u201384 doi: 10.1111\/j.1601-0825.2005.01144.x","journal-title":"Oral Dis"},{"key":"983_CR26","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/0-306-48382-3_14","volume":"528","author":"C Tanaka","year":"2003","unstructured":"Tanaka C, Matsuda T, Hayashi E, Imamura Y, Ozaki S (2003) Clinical manifestations and course of 200 Japanese patients with Behcet\u2019s disease. Adv Exp Med Biol 528:77\u201379 doi: 10.1007\/0-306-48382-3_14","journal-title":"Adv Exp Med Biol"},{"key":"983_CR27","first-page":"1120","volume":"61","author":"T Saylan","year":"1986","unstructured":"Saylan T, Ozarmagan G, Azizlerli G, Ovul C, Oke N (1986) Behcet disease in Turkey. Z Hautkr 61:1120\u20131122","journal-title":"Z Hautkr"},{"key":"983_CR28","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/b100540","volume-title":"Adamantiades-Beh\u00e7et\u2019s Disease","author":"CC Zouboulis","year":"2003","unstructured":"Zouboulis CC, Turnbull JR, Martus P (2003) Univariate and multivariate analyses comparing demographic, genetic, clinical, and serological risk factors for severe Adamantiades-Beh\u00e7et\u2019s Disease. In: Zouboulis CC (ed) Adamantiades-Beh\u00e7et\u2019s Disease. Kluwer\/Plenum, London Amsterdam, pp 123\u2013126"},{"key":"983_CR29","doi-asserted-by":"crossref","unstructured":"Krause L, K\u00f6hler AK, Altenburg A et al (2008) Ocular involvement is associated with HLA-B51 in Adamantiades-Beh\u00e7et\u2019s disease. Eye (Jun):13. Epub ahead of print","DOI":"10.1038\/eye.2008.177"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-008-0983-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-008-0983-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-008-0983-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T19:40:43Z","timestamp":1559072443000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-008-0983-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11,4]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["983"],"URL":"https:\/\/doi.org\/10.1007\/s00417-008-0983-4","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11,4]]}}}